查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1712509

全球組織水平植入物市場 - 2025 年至 2033 年

Global Tissue Level Implant Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2024 年全球組織級植入物市場規模達到 94.2 億美元，預計到 2033 年將達到 163.8 億美元，在 2025-2033 年預測期內的複合年成長率為 6.9%。

組織級植體是一種特殊類型的牙植體，其特點是其獨特的設計，其中植體和基台之間的界面位於骨水平上方，直接與牙齦組織接觸。這種設計對於癒合過程、病患照護和植入物的整體效果具有若干重要意義。

老年人口的增加和牙科疾病負擔的增加以及技術進步預計將推動市場成長。隨著年齡的成長，人們更容易因蛀牙、牙齦疾病和磨損等因素而失去牙齒。老年人群經常將植牙視為恢復口腔功能和美觀的長期解決方案，這增加了對組織級植牙的需求。

市場動態：

駕駛員和約束裝置

牙科植體需求不斷成長

老年人口的增加和牙科疾病負擔的增加預計將推動市場成長。隨著年齡的成長，人們更容易因蛀牙、牙齦疾病和磨損等因素而失去牙齒。老年人群經常將植牙視為恢復口腔功能和美觀的長期解決方案，這增加了對組織級植牙的需求。

例如，根據南加州大學赫爾曼·奧斯特羅牙科學院2024年的報告，估計65歲以上的成年人中約有5%是無牙的。此外，根據世界衛生組織2023年的報告，估計口腔疾病影響近35億人。牙科疾病的增加增加了對組織級植入物的需求並推動了市場成長。

此外，合作夥伴關係、協作和產品發布等主要參與者的策略將推動這一市場的成長。例如，2022 年 11 月，一家名為 Prayasta 的新創公司與印度科學研究所 (IISc) 合作開發了世界上第一台用於植入級矽膠的 3D 列印機，名為 Silimac。這項創新技術在印度理工學院生物系統科學與工程中心 (BSSE) 亮相，旨在在醫院環境中直接 3D 列印個人化矽膠植入物。

植入物成本高昂

組織級植入物成本高昂，嚴重限制了全球市場的發展，限制了患者的可近性，也為醫療保健提供者帶來了挑戰。組織級植入物需要高品質的生物相容性材料，例如鈦、氧化鋯或高級聚合物，這些材料成本昂貴。精密製造和消毒過程增加了整體成本。植入技術涉及大量的研發，以確保安全性、耐用性和與人體組織的兼容性。因此，上述因素可能會限制全球組織級植入物市場的潛在成長。

目錄

第1章：市場介紹和範圍

  • 報告目標
  • 報告範圍和定義
  • 報告範圍

第2章：高階主管見解與關鍵要點

  • 市場亮點和戰略要點
  • 主要趨勢和未來預測
  • 按類型分類的程式碼片段
  • 材料片段
  • 最終用戶的程式碼片段
  • 按地區分類

第3章：動態

  • 影響因素
    • 驅動程式
      • 牙科植體需求不斷成長
      • 技術進步
    • 限制
      • 植入物成本高昂
      • 與組織植入相關的困難
    • 機會
      • 新興市場的擴張
    • 影響分析

第4章：戰略洞察與產業展望

  • 市場領導者和先驅者
    • 新興先鋒和傑出參與者
    • 擁有最大銷售品牌的既定領導者
    • 擁有成熟產品的市場領導者
  • CXO 觀點
  • 最新進展與突破
  • 監管和報銷情況
    • 北美洲
    • 歐洲
    • 亞太地區
    • 南美洲
    • 中東和非洲
  • 波特五力分析
  • 供應鏈分析
  • 專利分析
  • SWOT分析
  • 未滿足的需求和差距
  • 市場進入和擴張的推薦策略
  • 情境分析：最佳情況、基本情況和最壞情況預測
  • 定價分析和價格動態
  • 關鍵意見領袖

第5章：組織級植入物市場（按類型）

  • 心血管植入物
  • 牙種植體
  • 乳房植入物
  • 臉部植入
  • 骨科植入物
  • 其他

第6章：組織級植入物市場（依材料）

  • 鈦
  • 氧化鋯
  • 鈷鉻合金
  • 聚醚醚酮
  • 聚丙烯
  • 其他

第7章：組織級植入物市場（依最終使用者）

  • 醫院和診所
  • 牙醫診所
  • 門診手術中心
  • 其他

第8章：組織級植入物市場，依區域市場分析與成長機會

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 中東和非洲

第9章：競爭格局與市場定位

  • 競爭概況和主要市場參與者
  • 市佔率分析與定位矩陣
  • 策略夥伴關係、併購
  • 產品組合和創新的關鍵發展
  • 公司基準化分析

第10章：公司簡介

  • Institut Straumann AG
    • 公司概況
    • 產品組合
      • 產品描述
      • 產品關鍵績效指標 (KPI)
      • 歷史和預測產品銷售
      • 產品銷售量
    • 財務概覽
      • 公司收入
      • 地區收入佔有率
      • 收入預測
    • 關鍵進展
      • 併購
      • 關鍵產品開發活動
      • 監管部門批准等
    • SWOT分析
  • Nobel Biocare Services AG
  • Dentsply Sirona
  • Zimmer Biomet
  • Biotech Dental
  • BioHorizons
  • TBR Dental
  • Hiossen Implant Canada INC.
  • Southern Implant
  • Implant Direct

第 11 章：假設與研究方法

  • 資料收集方法
  • 數據三角測量
  • 預測技術
  • 數據驗證和確認

第 12 章：附錄

簡介目錄
Product Code: MD4253

The global tissue-level implant market reached US$ 9.42 billion in 2024 and is expected to reach US$ 16.38 billion by 2033, growing at a CAGR of 6.9 % during the forecast period of 2025-2033.

Tissue-level implants are a specialized type of dental implant characterized by their unique design, where the interface between the implant and the abutment is positioned above the bone level, directly in contact with the gum tissue. This design has several important implications for the healing process, patient care, and overall effectiveness of the implant.

The increasing geriatric population and the increasing burden of dental diseases, Rising geriatric population and burden of dental diseases, and technological advancements are expected to drive the market growth. People are more likely to lose teeth as they become older due to factors like decay, gum disease, and wear over time. The senior population frequently considers dental implants as a long-term solution for restoring oral function and aesthetics, increasing demand for tissue-level implants.

Market Dynamics: Drivers & Restraints

Increasing Demand for Dental Implants

The increasing geriatric population and the increasing burden of dental diseases are expected to drive the market growth. People are more likely to lose teeth as they become older due to factors like decay, gum disease, and wear over time. The senior population frequently considers dental implants as a long-term solution for restoring oral function and aesthetics, increasing demand for tissue-level implants.

For instance, according to the report by the Herman Ostrow School of Dentistry of USC in 2024, it is estimated that around 5% of adults older than 65 years are edentulous. Additionally, according to the report by the World Health Organization in 2023, it is estimated that oral diseases affect nearly 3.5 billion people. The increasing number of dental diseases increases demand for tissue-level implants and drives market growth.

Furthermore, key players' strategies such as partnerships & collaborations, and product launches would drive this market growth. For instance, in November 2022, a startup named Prayasta, in collaboration with the Indian Institute of Science (IISc), developed the world's first 3D printer for implant-grade silicone, named Silimac. This innovative technology was unveiled at the IISc's Centre for BioSystems Science and Engineering (BSSE) and is designed to directly 3D print personalized silicone implants within a hospital setting.

High Costs of Implants

The high cost of tissue-level implants is a significant restraint in the global market, limiting accessibility for patients and creating challenges for healthcare providers. Tissue-level implants require high-quality biocompatible materials such as titanium, zirconia, or advanced polymers, which are costly. The precision manufacturing and sterilization processes add to the overall expense. Implant technology involves extensive R&D to ensure safety, durability, and compatibility with human tissues. Thus, the above factors could be limiting the global tissue-level implant market's potential growth.

Segment Analysis

The global tissue-level implant market is segmented based on type, material, end-user, and region.

Type:

The dental implant segment in type is expected to dominate the global tissue-level implant market with the highest market share

Dental implants are an artificial solution for tooth replacement, designed to provide a permanent and functional alternative to traditional prosthetics such as dentures and bridges. The rise in dental diseases, particularly periodontal disease and dental caries, is a significant driver of demand for dental implants. This demand is largely fueled by the consequences of these conditions, which often lead to tooth loss and the subsequent need for effective replacement solutions.

According to WHO data in March 2023, the prevalence of dental diseases, particularly dental caries and periodontal disease, is a significant public health concern globally. An estimated 2 billion people suffer from caries of permanent teeth, and 514 million children are affected by caries of primary teeth. This widespread occurrence is exacerbated by factors such as urbanization and changing living conditions, which contribute to the increasing prevalence of these oral diseases.

Innovations in materials, technology, and surgical techniques have enhanced the appeal of dental implants among both patients and practitioners. As advancements continue to evolve within this field, dental implants are increasingly recognized as the gold standard for tooth replacement solutions, offering lasting benefits that align with modern expectations for oral health and aesthetics.

Furthermore, key players in the industry product launchers that would drive this market growth. For instance, Nobel Biocare introduced two advanced surfaces for dental implants: Xeal for abutments and TiUltra for implants. These surfaces leverage Nobel Biocare's extensive expertise in anodization technology, which is crucial for optimizing tissue integration at every level of the implant system, from the abutment to the apex.

For instance, in March 2022, Bredent Medical launched a new generation of whiteSKY zirconia implants, enhancing its existing line of ceramic dental implants. This updated implant system is designed to meet the growing demand for aesthetic and biocompatible dental solutions, particularly for patients who prefer metal-free options. These factors have solidified the segment's position in the global tissue-level implant market.

Geographical Analysis

North America is expected to hold a significant position in the global tissue-level implant market with the highest market share

There is an increasing number of periodontal diseases in the North America region. Gum (periodontal) disease is a broad term for gingivitis and periodontitis. These conditions involve infection and inflammation of the tissues (e.g., gum and bone) around the teeth.

For instance, according to the World Health Organization (WHO), the most common oral health conditions include cavities, gum disease, tooth loss, and oral cancer. About 90% of U.S. adults 20 years and older have experienced at least one cavity. Nearly half (42%) of U.S. adults have periodontal (gum) disease. Thus, the above factors are expected to hold the region in the dominant position during the forecast period.

Continuous innovations in implant materials (like titanium and zirconia), design, and surgical techniques have improved the success rates of tissue-level implants. Enhanced biocompatibility and osseointegration properties make these implants more appealing to both patients and healthcare providers. Moreover, in this region, a majority of key players' presence, well-advanced healthcare infrastructure, government initiatives & regulatory support, technological advancements, & investments, and product launches & approvals would propel this market growth.

For instance, in February 2024, American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting, Anika Therapeutics launched the Integrity Implant System and the RevoMotion Reverse Shoulder Arthroplasty System, along with other key regenerative products. This event is a significant gathering for orthopedic professionals, showcasing the latest advancements in orthopedic surgery and rehabilitation.

Similarly, in June 2023, the FDA approved the SNUCONE Co., Ltd., developed the SNUCONE Tissue Level Implant System, which is designed for use in dental applications, specifically for partially or fully edentulous (toothless) mandibles (lower jaw) and maxillae (upper jaw). The system is intended to support single or multiple dental restorations, making it a versatile option for patients requiring dental implants. Thus, the above factors are consolidating the region's position as a dominant force in the global tissue-level implant market.

Competitive Landscape

The major global players in the tissue-level implant market include Institut Straumann AG, Nobel Biocare Services AG, Dentsply Sirona, Zimmer Biomet, Biotech Dental, BioHorizons, TBR Dental, Hiossen Implant Canada INC., Southern Implant, and Implant Direct, among others.

Key Developments

  • In January 2023, MediNiche introduced Bone-Tite, the first dietary supplement specifically designed for dental implant patients. Bone-Tite aims to provide nutritional support before and after dental implant procedures, addressing the critical role that nutrition plays in the osseointegration process and the integration of the implant with the surrounding bone.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials and product pipelines and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzed product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: This covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyze competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global tissue-level implant market report delivers a detailed analysis with 62 key tables, more than 59 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Type
  • 2.4. Snippet by Material
  • 2.5. Snippet by End-User
  • 2.6. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Increasing Demand for Dental Implants
      • 3.1.1.2. Technological Advancements
    • 3.1.2. Restraints
      • 3.1.2.1. High Costs of Implants
      • 3.1.2.2. Difficulties Associated with Tissue Implants
    • 3.1.3. Opportunity
      • 3.1.3.1. Expansion in Emerging Markets
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with the largest-selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. CXO Perspectives
  • 4.3. Latest Developments and Breakthroughs
  • 4.4. Regulatory and Reimbursement Landscape
    • 4.4.1. North America
    • 4.4.2. Europe
    • 4.4.3. Asia Pacific
    • 4.4.4. South America
    • 4.4.5. Middle East & Africa
  • 4.5. Porter's Five Forces Analysis
  • 4.6. Supply Chain Analysis
  • 4.7. Patent Analysis
  • 4.8. SWOT Analysis
  • 4.9. Unmet Needs and Gaps
  • 4.10. Recommended Strategies for Market Entry and Expansion
  • 4.11. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.12. Pricing Analysis and Price Dynamics
  • 4.13. Key Opinion Leaders

5. Tissue Level Implant Market, By Type

  • 5.1. Introduction
    • 5.1.1. Analysis and Y-o-Y Growth Analysis (%), By Type
    • 5.1.2. Market Attractiveness Index By Type
  • 5.2. Cardiovascular Implants*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 5.3. Dental Implant
  • 5.4. Breast Implant
  • 5.5. Facial Implant
  • 5.6. Orthopaedic Implants
  • 5.7. Others

6. Tissue Level Implant Market, By Material

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 6.1.2. Market Attractiveness Index By Material
  • 6.2. Titanium*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Zirconia
  • 6.4. Cobalt-Chromium Alloys
  • 6.5. Polyetheretherketone
  • 6.6. Polypropylene
  • 6.7. Others

7. Tissue Level Implant Market, By End-User

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 7.1.2. Market Attractiveness Index, By End-User
  • 7.2. Hospitals & Clinics*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Dental Clinics
  • 7.4. Ambulatory Surgical Centers
  • 7.5. Others

8. Tissue Level Implant Market, By Regional Market Analysis and Growth Opportunities

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 8.1.2. Market Attractiveness Index, By Region
  • 8.2. North America
    • 8.2.1. Introduction
    • 8.2.2. Key Region-Specific Dynamics
    • 8.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 8.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 8.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.2.6.1. U.S.
      • 8.2.6.2. Canada
      • 8.2.6.3. Mexico
  • 8.3. Europe
    • 8.3.1. Introduction
    • 8.3.2. Key Region-Specific Dynamics
    • 8.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 8.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 8.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.3.6.1. Germany
      • 8.3.6.2. U.K.
      • 8.3.6.3. France
      • 8.3.6.4. Spain
      • 8.3.6.5. Italy
      • 8.3.6.6. Rest of Europe
  • 8.4. South America
    • 8.4.1. Introduction
    • 8.4.2. Key Region-Specific Dynamics
    • 8.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 8.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 8.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.4.6.1. Brazil
      • 8.4.6.2. Argentina
      • 8.4.6.3. Rest of South America
  • 8.5. Asia-Pacific
    • 8.5.1. Introduction
    • 8.5.2. Key Region-Specific Dynamics
    • 8.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 8.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 8.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.5.6.1. China
      • 8.5.6.2. India
      • 8.5.6.3. Japan
      • 8.5.6.4. South Korea
      • 8.5.6.5. Rest of Asia-Pacific
  • 8.6. Middle East and Africa
    • 8.6.1. Introduction
    • 8.6.2. Key Region-Specific Dynamics
    • 8.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 8.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 8.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

9. Competitive Landscape and Market Positioning

  • 9.1. Competitive Overview and Key Market Players
  • 9.2. Market Share Analysis and Positioning Matrix
  • 9.3. Strategic Partnerships, Mergers & Acquisitions
  • 9.4. Key Developments in Product Portfolios and Innovations
  • 9.5. Company Benchmarking

10. Company Profiles

  • 10.1. Institut Straumann AG*
    • 10.1.1. Company Overview
    • 10.1.2. Product Portfolio
      • 10.1.2.1. Product Description
      • 10.1.2.2. Product Key Performance Indicators (KPIs)
      • 10.1.2.3. Historic and Forecasted Product Sales
      • 10.1.2.4. Product Sales Volume
    • 10.1.3. Financial Overview
      • 10.1.3.1. Company Revenue
      • 10.1.3.2. Geographical Revenue Shares
      • 10.1.3.3. Revenue Forecasts
    • 10.1.4. Key Developments
      • 10.1.4.1. Mergers & Acquisitions
      • 10.1.4.2. Key Product Development Activities
      • 10.1.4.3. Regulatory Approvals, etc.
    • 10.1.5. SWOT Analysis
  • 10.2. Nobel Biocare Services AG
  • 10.3. Dentsply Sirona
  • 10.4. Zimmer Biomet
  • 10.5. Biotech Dental
  • 10.6. BioHorizons
  • 10.7. TBR Dental
  • 10.8. Hiossen Implant Canada INC.
  • 10.9. Southern Implant
  • 10.10. Implant Direct

LIST NOT EXHAUSTIVE

11. Assumptions and Research Methodology

  • 11.1. Data Collection Methods
  • 11.2. Data Triangulation
  • 11.3. Forecasting Techniques
  • 11.4. Data Verification and Validation

12. Appendix

  • 12.1. About Us and Services
  • 12.2. Contact Us